Publications

  1. Seshadri A, Prokop LJ, Singh B. Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. J Affect Disord. 2024 Jul 1; 356:379-384 Epub 2024 Mar 26
    View PubMed
  2. Kumar R, Nunez NA, Joshi N, Joseph B, Verde A, Seshadri A, Cuellar Barboza AB, Prokop LJ, Medeiros GC, Singh B. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review. Bipolar Disord. 2024 Jun; 26 (4):321-330 Epub 2024 Feb 07
    View PubMed
  3. Kumar R, LeMahieu AM, Stan MN, Seshadri A, Ozerdem A, Pazdernik VK, Haynes TL, Daugherty DH 3rd, Sundaresh V, Veldic M, Croarkin PE, Frye MA, Singh B. The Association Between Thyroid Stimulating Hormone and Depression: A Historical Cohort Study. Mayo Clin Proc. 2023 Jul; 98 (7):1009-1020
    View PubMed
  4. Singal P, Nunez NA, Joseph B, Hassett LC, Seshadri A, Singh B. Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review. Brain Sci. 2023 Mar 25; 13 (4)
    View PubMed
  5. Yousufuddin M, Yamani MH, Kashani KB, Zhu Y, Wang Z, Seshadri A, Blocker KR, Peters JL, Doss JM, Karam D, Khandelwal K, Sharma UM, Dudenkov DV, Mehmood T, Pagali SR, Nanda S, Abdalrhim AD, Cummings N, Dugani SB, Smerina M, Prokop LJ, Keenan LR, Bhagra S, Jahangir A, Bauer PR, Fonarow GC, Murad MH. Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations During the COVID-19 Pandemic, March to October 2020. Mayo Clin Proc. 2023 Jan; 98 (1):31-47 Epub 2022 Sept 21
    View PubMed
  6. Seshadri A, Sundaresh V, Prokop LJ, Singh B. Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review. Brain Sci. 2022 Nov 14; 12 (11)
    View PubMed
  7. Nunez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, Veldic M, Seshadri A, Biernacka JM, Frye MA, Wang Z, Singh B. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. J Affect Disord. 2022 Apr 1; 302:385-400 Epub 2022 Jan 02
    View PubMed
  8. Seshadri A, Wermers ME, Habermann TJ, Singh B. Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis. Prim Care Companion CNS Disord. 2021 Jun 24; 23 (4) Epub 2021 June 24
    View PubMed
  9. Patel UK, Anwar A, Saleem S, Malik P, Rasul B, Patel K, Yao R, Seshadri A, Yousufuddin M, Arumaithurai K. Artificial intelligence as an emerging technology in the current care of neurological disorders. J Neurol. 2021 May; 268 (5):1623-1642 Epub 2019 Aug 26
    View PubMed
  10. Seshadri A, Orth SS, Adaji A, Singh B, Clark MM, Frye MA, McGillivray J, Fuller-Tyszkiewicz M. Mindfulness-Based Cognitive Therapy, Acceptance and Commitment Therapy, and Positive Psychotherapy for Major Depression. Am J Psychother. 2021 Mar 1; 74 (1):4-12 Epub 2020 Sept 28
    View PubMed
  11. Seshadri A, Adaji A, Orth SS, Singh B, Clark MM, Frye MA, Fuller-Tyszkiewicz M, McGillivray J. Exercise, Yoga, and Tai Chi for Treatment of Major Depressive Disorder in Outpatient Settings: A Systematic Review and Meta-Analysis. Prim Care Companion CNS Disord 2020 Dec 31; 23 (1)
    View PubMed
  12. Yousufuddin M, Moriarty JP, Lackore KA, Zhu Y, Peters JL, Doyle T, Jensen KL, Ahmmad EM, Al Ward RY, Al-Zu'bi HM, Sharma UM, Seshadri A, Arumaithurai K, Keenan LR, Bhagra S, Murad MH, Borah BJ. Initial and subsequent 3-year cost after hospitalization for first acute ischemic stroke and intracerebral hemorrhage. J Neurol Sci. 2020 Dec 15; 419:117181. Epub 2020 Oct 18.
    View PubMed
  13. Nunez NA, Joseph B, Pahwa M, Seshadri A, Prokop LJ, Kung S, Schak KM, Vande Voort JL, Frye MA, Singh B. An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2020 Sep 14; 50 (4):137-163
    View PubMed
  14. Pahwa M, Nunez NA, Joseph B, Seshadri A, Gerberi DJ, Frye MA, Singh B. Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2020 Sep 14; 50 (4):118-136
    View PubMed
  15. Seshadri A, Clark MM, Kung S, Fuller-Tyszkiewicz M, Sood A, Dammen KC, Rico JA, Tye SJ, McGillivray J, Frye MA. Feasibility Study of Stress Management and Resiliency Training (SMART) in Patients With Major Depressive Disorder. Prim Care Companion CNS Disord. 2020 Apr 30; 22 (3)
    View PubMed
  16. Yousufuddin M, Takahashi PY, Major B, Ahmmad E, Al-Zubi H, Peters J, Doyle T, Jensen K, Al Ward RY, Sharma U, Seshadri A, Wang Z, Simha V, Murad MH. Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis. BMJ Open. 2019 Dec 15; 9 (12):e028638
    View PubMed
  17. Angstman KB, Seshadri A, Marcelin A, Gonzalez CA, Garrison GM, Allen JS. Personality Disorders in Primary Care: Impact on Depression Outcomes Within Collaborative Care. J Prim Care Community Health. 2017 Oct; 8 (4):233-238 Epub 2017 June 14
    View PubMed
  18. Baslet G, Seshadri A, Bermeo-Ovalle A, Willment K, Myers L. Psychogenic Non-epileptic Seizures: An Updated Primer. Psychosomatics. 2016 Jan-Feb; 57 (1):1-17 Epub 2015 Oct 22
    View PubMed
  19. Seshadri A, Ramu M, Deepa R, Mohan V. Prevalence of Neuropathy in Type II Diabetic patients attending a Diabetic Centre in South India. Journal of Association of Physicians of India. 1/2002; 50:546-550.